Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW 5,030.00
+210.00 (4.36%)
Oct 11, 2024, 10:09 AM KST
Bridge Biotherapeutics Revenue
Bridge Biotherapeutics had revenue of -340.00 KRW in the twelve months ending June 30, 2024, down -100.00% year-over-year. In the year 2023, Bridge Biotherapeutics had annual revenue of 100.00M, down -96.69%.
Revenue (ttm)
-340.00
Revenue Growth
-100.00%
P/S Ratio
n/a
Revenue / Employee
-9.71
Employees
35
Market Cap
229.43B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition